What are some of Roche's key contributions to cancer treatment?
Roche has developed several groundbreaking cancer therapies. Some of their most well-known drugs include Herceptin (trastuzumab), which targets HER2-positive breast cancer, and Avastin (bevacizumab), used for various types of cancer including colorectal, lung, and kidney cancers. Another notable drug is Perjeta (pertuzumab), also for HER2-positive breast cancer, often used in combination with Herceptin.
